Patients with HCC with MELD(-Na) >19, AFP >24 ng/ml, and total tumour diameter >3.2 cm had the worst post-transplant 5-year survival rates (58.1%; 95% CI 50.2–67.2%). This evidence concerns the gene AFP and hepatocellular carcinoma.